Showing results (81-90 of 651) with videos related to

Sort By:
Pageof 66
Cancers|August 12, 2023
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary CarcinomaChijioke Nze, Pavlos Msaouel, Mohamed H Derbala, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Trastuzumab Deruxtecan in HER2-Low or HER2-Mutant Recurrent/Metastatic Secretory Gland Cancers of the Head and Neck: A Case SeriesMichael T Wotman, Alexander Khalaf, Kaiwen Wang, et al.
Oncotarget|March 28, 2020
Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN lossNicci Owusu-Brackett, Ming Zhao, Argun Akcakanat, et al.
Breast Cancer Research and Treatment|March 11, 2008
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancerJulie E Lang, Kailash Mosalpuria, Massimo Cristofanilli, et al.
Iscience|June 24, 2026
The WEE1 inhibitor azenosertib broadly enhances efficacy of antibody-drug conjugates with topoisomerase I and microtubule inhibitor payloadsXiao Guo, Doris Kim, Olivier Harismendy, et al.
Cancer Research|March 9, 2005
Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivityJinjiang Dong, Junying Peng, Haixia Zhang, et al.
JCO Clinical Cancer Informatics|January 6, 2022
Natural Language Processing-Assisted Literature Retrieval and Analysis for Combination Therapy in CancerJia Zeng, Christian X Cruz-Pico, Turçin Saridogan, et al.
Cell Reports. Medicine|April 21, 2026
Targeting RNase H2: A dual-mechanism strategy to elevate replication stress, DNA damage, and antitumor immunity in TNBCThai Quynh Anh Nguyen, Jing Zhang, Hui Dai, et al.
Investigational New Drugs|October 1, 2016
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceManojkumar Bupathi, Joud Hajjar, Stacie Bean, et al.
Pageof 66